The report “Electrical Ablation Market forecast, 2010-2018” analyzes the market of devices by 7 segments such as Electrical Ablators and Electronic Brachytherapy. The high (above 70%) success rate for removal of arrhythmic heart conditions is the major factor that is driving this market. Globally, there are over 14 million arrhythmia cases with fatality of 15% annually. It affects over 10% of population over the age of 80 globally. This rate of increase in heart conditions is predicted to sustain the electrical ablation technology market through 2016, at a low CAGR of just 5.2%.
The American Electrical Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery was valued at $387 million in 2013 and is expected to reach $480 million by 2018,. In electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011.
Tachycardia, Atrial Arrhythmia conditions occur in people where cardiac electrical impulses move abnormally through a deviated path involving extra tissue and this impulse creates an abnormal pattern of elevated or decreased heart-beats in a patient. Electrical ablation is used for such conditions and involves ablating healthy cells so as to cut off electrical impulses transmitted that cause uneven heart beats. The procedure can be done percutaneously or by minimally invasive technique using ultrasound imaging, fluoroscopy, MRI etc.
Due to huge obese population (~30% of U.S. population) and high diabetic patient pool, it is expected that incidences of cardiovascular related disorders will continue to grow in the future. As established market players consider cancer and cardiovascular diseases as the top application, and majorly focused areas, the Americas will continue to be a big market for ablation devices and will continue to offer opportunities in future. As the number of patient population will increase it will lead to increase in the procedural volume of minimally invasive surgeries, ultimately giving rise to increased demand for electrical ablation devices.
Traditional electrical ablation probes are not effective for ablating certain tissue types such as adhesions which develop in a large fraction of patients after surgery. Thus, there is an unmet need for devices that are suitable for ablating a variety of abnormal tissues, adhesions, and fibrous growths. Minimally invasive surgical devices are yet another area of expansion for market players in the ablation technologies market.
The report also provides an extensive competitive landscaping of companies operating in electrical ablation market. The main companies operating in electrical ablation market are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific (U.S), Angiodynamics (U.S), and Covidien (Ireland).
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
The market data enables you to customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
- Country specific Prevalence of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
- Country specific Patient pool of cancer, cardiovascular disorders, gynecological, and orthopedic disorders.
- Disease progression (Pattern analysis)
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology date
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Americas Thermal Ablation
The American Thermal Ablation Market was pegged at $3097 million in 2013 and expected to be $5012 million by 2018. The main companies operating in thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others
Asia-Pacific Thermal Ablation
The Asia-Pacific Thermal Ablation Market was pegged at $1533 million in 2013 and expected to be $2772 million by 2018. The main companies operating in Asia-Pacific Thermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
European Thermal Ablation
The European Thermal Ablation Market was pegged at $2132 million in 2013 and expected to be $3328 million by 2018. The main companies operating in European thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.